Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07705022Phase 2Enrolling by invitation
A Phase 2 trial of dexmedetomidine, ketamine, sponsored by University of Michigan. Started Aug 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07705022.